While the consultation is open you can make a submission at our TGA consultation hub.
We review the submissions carefully. After that the submissions and our decision will be available on the same page at the TGA consultation hub.
Overview
Scheduling amendments referred to expert advisory committee
Please note that there is a separate consultation for interim decisions relating to PSILOCYBINE and MDMA which can be found by clicking the link below:
This consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the June 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
The closing date for this consultation is close of business 24 November 2022. All submissions received by the deadline will be considered by the delegate before they make a final decision.
The interim decisions under consultation are detailed in the public notice of interim decisions of June 2022.
Substances in this consultation:
- Cetirizine
- Budesonide
- Apronal (allylisopropylacetylurea)
- Helional
- Hydroxypinacolone retinoate
- Renaming of MDMA and MDA (midomefetamine and tenamfetamine)
- Dichloromethane
- Ipflufenoquin
All current TGA consultations can be found at the TGA consultation hub.